Skip to content

Safety and Performance of New 2-piece Ostomy Product Concept Compared With SenSura Click in Subjects With Ileostomy

Investigating the Safety and Performance of New 2-piece Ostomy Product Concept Compared With SenSura Click in Subjects With Ileostomy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01800890
Enrollment
31
Registered
2013-02-28
Start date
2013-02-28
Completion date
2013-04-30
Last updated
2014-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subjects With an Ileostomy

Keywords

stoma ileostomy

Brief summary

The aim of the current clinical investigation is to evaluate the performance and safety of new 2-piece ostomy product concepts.

Detailed description

The new products have been developed to reduce the degree of leakage and other problems related to ostomy appliances in people with a stoma.

Interventions

DEVICEColoplast A

Coloplast A is a newly developed 2-piece ostomy appliance

DEVICEColoplast B

Coloplast B is a newly developed 2-piece ostomy appliance

DEVICEColoplast C

Coloplast C is a newly developed 2-piece ostomy appliance

DEVICESenSura Click

The comparator product is the commercial and CE-marked SenSura Click (2-piece) manufactured by Coloplast A/S.

Sponsors

Coloplast A/S
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Have given written informed consent and signed letter of authority form. 2. Be at least 18 years of age and have full legal capacity. 3. Be able to handle the appliances themselves 4. Have an ileostomy with a diameter between 15 and 40 mm. 5. Have had their ostomy for at least three months. 6. Use minimum 1 baseplate every third day. 7. Currently use 2-piece flat mechanical coupling product with open bag and a coupling size in the inter val of 43-55mm (both extremes included) 8. Must be able to use custom cut product 9. Accept to test three 2-piece products within the study. 10. Negative result of a pregnancy test for women of childbearing age.

Exclusion criteria

1. Use irrigation during the study (flush the stoma with water). 2. Currently receiving or have within the past 2 months received radio- and/or chemotherapy. 3. Currently receiving or have within the past month received local or systemic steroid treatment in the peristomal area. 4. Are pregnant or breastfeeding. 5. Participating in other interventional clinical investigations or have previously participated in this investigation. 6. More than three days wear time as usual change pattern. 7. Currently using ostomy belt 8. Currently using extended wear product (Sensura Xpro, Assura TERA, Dansac NovaLife X3, Hollister Flextend, Convatec Durahesive) 9. Have a loop ileostomy 10. Known hypersensitivity towards any of the test products 11. Suffer from peristomal skin problems that preclude participation in the investigation (assessed by the investigation nurse)

Design outcomes

Primary

MeasureTime frameDescription
Degree of Leakage10 daysThe degree of leakage is assessed using a 4 point leakage scale developed by Coloplast A/S. The 4-point leakage scale has four choices 1. No leakage 2. Starting to leakage 3. Leakage 4. Sudden leakage Leakage was assessed at every baseplate change

Countries

Denmark

Participant flow

Recruitment details

The subject were recruited through the Coloplast user data base.

Pre-assignment details

Thirty-one subjects signed the informed consent, but 2 subjects were screen failures and did not test any products. These two subjects are not included in the participant flow below.

Participants by arm

ArmCount
Overall Study Population
baseline data is given for subjects in the ITT population
28
Total28

Baseline characteristics

CharacteristicOverall Study Population
Age, Continuous61.7 years
STANDARD_DEVIATION 8.6
Sex: Female, Male
Female
5 Participants
Sex: Female, Male
Male
23 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —— / —
other
Total, other adverse events
6 / 198 / 194 / 196 / 28
serious
Total, serious adverse events
0 / 190 / 190 / 191 / 28

Outcome results

Primary

Degree of Leakage

The degree of leakage is assessed using a 4 point leakage scale developed by Coloplast A/S. The 4-point leakage scale has four choices 1. No leakage 2. Starting to leakage 3. Leakage 4. Sudden leakage Leakage was assessed at every baseplate change

Time frame: 10 days

ArmMeasureValue (MEAN)Dispersion
Coloplast Test Product ADegree of Leakage1.8 units on a scaleStandard Deviation 0.7
Coloplast Test Product BDegree of Leakage1.8 units on a scaleStandard Deviation 0.7
Coloplast Test Product CDegree of Leakage1.9 units on a scaleStandard Deviation 0.9
SenSuraDegree of Leakage1.7 units on a scaleStandard Deviation 0.8

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026